News
VitaDX was present at SANTEXPO 2022 to attend the Workshop "How to accelerate to Europe?"
VitaDX attended the first public conference dedicated to bladder cancer, organized by the University Hospital of Rennes and the Eugène Marquis…
Allan Rodriguez - CEO of VitaDX was interviewed by Destination Rennes to present the startup VitaDX and its in vitro diagnostic medical device…
Thanks to Ouest France for this very nice article.
VitaDX has been partnering for several years with LTSI (Signal and Image Processing…
Thomas Hugues welcomes Allan Rodriguez (VitaDX) and Camélia Radulescu (Foch hospital) to ÉCOSYSTÈME to talk about VitaDX's new diagnostic solution…
VitaDX completes a €3M financing round with its historical investors GO CAPITAL, ODYSSEE Venture and FFBB Management and its financial partners…
VitaDX is very proud to announce the CE marking of its first software solution dedicated to bladder cancer diagnosis: VisioCyt®.
This fundraising will allow VitaDX to finalize the development and ensure the commercial deployment of its first early bladder cancer detection…
Allan Rodriguez (CEO and co-founder of VitaDX) and Pascal Eschwège (Professor of Urology at the University Hospital of Nancy and co-founder of…
VitaDX was present at SANTEXPO 2022 to attend the Workshop "How to accelerate to Europe?"
VitaDX attended the first public conference dedicated to bladder cancer, organized by the University Hospital of Rennes and the Eugène Marquis…
Allan Rodriguez - CEO of VitaDX was interviewed by Destination Rennes to present the startup VitaDX and its in vitro diagnostic medical device…
Thanks to Ouest France for this very nice article.
VitaDX has been partnering for several years with LTSI (Signal and Image Processing…
Thomas Hugues welcomes Allan Rodriguez (VitaDX) and Camélia Radulescu (Foch hospital) to ÉCOSYSTÈME to talk about VitaDX's new diagnostic solution…
VitaDX completes a €3M financing round with its historical investors GO CAPITAL, ODYSSEE Venture and FFBB Management and its financial partners…
VitaDX is very proud to announce the CE marking of its first software solution dedicated to bladder cancer diagnosis: VisioCyt®.
This fundraising will allow VitaDX to finalize the development and ensure the commercial deployment of its first early bladder cancer detection…
Allan Rodriguez (CEO and co-founder of VitaDX) and Pascal Eschwège (Professor of Urology at the University Hospital of Nancy and co-founder of…